ADCT-402

· ADC Therapeutics S.A.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ADCT-402, covering 2019-09-26 to 2020-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL) [Phase 1]